Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pauline, Funchain"'
Publikováno v:
JAAD International. 11:220-221
Publikováno v:
Chest. 162:A1629-A1630
Autor:
Stephanie Saridakis, Giovanni Damiani, Rosalynn R.Z. Conic, Jennifer S. Ko, Brian R. Gastman, Allison T. Vidimos, Pauline Funchain
Publikováno v:
Journal of the American Academy of Dermatology. 81:364-372
Merkel cell carcinoma (MCC) is a rare, aggressive malignancy with high rates of recurrence and metastasis.To evaluate predictors of sentinel lymph node (SLN) positivity in MCC using the National Cancer Database.The National Cancer Database, from 2012
Autor:
Thomas Knackstedt, Jennifer S. Ko, Giovanni Damiani, Allison T. Vidimos, Alok Vij, Brian R. Gastman, Pauline Funchain, Rosalynn R.Z. Conic
Publikováno v:
Journal of the American Academy of Dermatology. 80:441-447
Sentinel lymph node biopsy (SLNB) specimens are often obtained from patients for further staging after these patients have undergone melanoma excision. Limited data regarding predictors of SLNB positivity in thin melanoma are available.We sought to e
Autor:
Jessica Philpott, Tapas Ranjan Behera, Joshua Arbesman, Jung Min Song, Jennifer S. Ko, Pauline Funchain
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 4, Iss, Pp 100091-(2021)
Immune checkpoint inhibitor (ICI) therapy is highly effective in managing several malignancies, however ICI can induce unique toxicities known as immune related adverse events (irAEs). A wide range of dermatologic irAEs including localized lichenoid
Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma
Autor:
Brian R. Gastman, Pauline Funchain, Evan Stiegel, David D. Xiong, Raymond Isakov, Jason Ya, Alok Vij
Publikováno v:
Journal of the American Academy of Dermatology. 78:942-948
Background Sentinel lymph node (SLN) biopsy is widely performed for melanoma with certain histologic parameters and offers important prognostic and staging information. Breslow thickness (BT) by itself also provides meaningful prognostic information.
Autor:
Naseer Sangwan, Bicky Thapa, Lorenzo Gervaso, John Barnard, Shadi Swaidani, Ann S. Kim, C. Marcela Diaz-Montero, Keith R. McCrae, Joanna Roopkumar, Alok A. Khorana, Patricia Rayman, Brian P. Hobbs, Suman Kundu, Pauline Funchain, Paul G. Pavicic, Wei Wei, Tyler Alban
Publikováno v:
Med (N Y)
BACKGROUND: Cancer immunotherapy is associated with several immune-related adverse events, but the relationship between immunotherapy and venous thromboembolism has not been thoroughly studied. METHODS: We conducted a retrospective cohort study of 1,
Autor:
Pauline Funchain, Charis Eng, Richard J. Jurevic, Mauricio Retuerto, Brian B. Burkey, Nicole Fowler, Mahmoud A. Ghannoum, Pranab K. Mukherjee
Publikováno v:
BBA Clinical
Background Metabolomics represents a promising approach for discovering novel targets and biomarkers in head and neck squamous cell carcinoma (HNSCC). Here we used metabolomics to identify oral metabolites associated with HNSCC. Methods Tumor and adj
Publikováno v:
Seminars in Oncology. 43:609-614
Hereditary cancer syndromes generally account for 5%-10% of malignancies. While these syndromes are rare, affected patients carry significantly elevated risks of developing cancer, as do their at-risk relatives. Identification of these patients is cr
Publikováno v:
Journal of Investigative Dermatology. 139:B21